|
1
|
Song H, Ekheden IG, Zheng Z, Ericsson J,
Nyrén O and Ye W: Incidence of gastric cancer among patients with
gastric precancerous lesions: observational cohort study in a low
risk Western population. BMJ. 351:h38672015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK,
Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, et al: Clinical practice
guidelines for gastric cancer in Korea: An evidence-based approach.
J Gastric Cancer. 14:87–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Long ZW, Yu HM, Wang YN, Liu D, Chen YZ,
Zhao YX and Bai L: Association of IL-17 polymorphisms with gastric
cancer risk in Asian populations. World J Gastroenterol.
21:5707–5718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen XZ, Chen H, Castro FA, Hu JK and
Brenner H: Epstein-Barr virus infection and gastric cancer: A
systematic review. Medicine (Baltimore). 94:e7922015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei W, Wang Y, Yu X, Ye L, Jiang Y and
Cheng Y: Expression of TP53, BCL-2, and VEGFA genes in esophagus
carcinoma and its biological significance. Med Sci Monit.
21:3016–3022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luanpitpong S, Chanvorachote P, Stehlik C,
Tse W, Callery PS, Wang L and Rojanasakul Y: Regulation of
apoptosis by Bcl-2 cysteine oxidation in human lung epithelial
cells. Mol Biol Cell. 24:858–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hajnóczky G, Csordás G, Das S,
Garcia-Perez C, Saotome M, Roy Sinha S and Yi M: Mitochondrial
calcium signalling and cell death: Approaches for assessing the
role of mitochondrial Ca2+ uptake in apoptosis. Cell
Calcium. 40:553–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ardi VC, Alexander LD, Johnson VA and
McAlpine SR: Macrocycles that inhibit the binding between heat
shock protein 90 and TPR-containing proteins. ACS Chem Biol.
6:1357–1366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo
X, Mao XH, Zou QM, Yu PW, Zuo QF, et al: Plasma microRNAs, miR-223,
miR-21 and miR-218, as novel potential biomarkers for gastric
cancer detection. PLoS One. 7:e416292012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hudler P: Challenges of deciphering
gastric cancer heterogeneity. World J Gastroenterol.
21:10510–10527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu HS and Xiao HS: MicroRNAs as potential
biomarkers for gastric cancer. World J Gastroenterol.
20:12007–12017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lakomy R, Sana J, Hankeova S, Fadrus P,
Kren L, Lzicarova E, Svoboda M, Dolezelova H, Smrcka M, Vyzula R,
et al: MiR-195, miR-196b, miR-181c, miR-21 expression levels and
O-6-methylguanine-DNA methyltransferase methylation status are
associated with clinical outcome in glioblastoma patients. Cancer
Sci. 102:2186–2190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Banzhaf-Strathmann J and Edbauer D: Good
guy or bad guy: The opposing roles of microRNA 125b in cancer. Cell
Commun Signal. 12:302014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim L, Balakrishnan A, Huskey N, Jones KD,
Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through suppression of
mutated in colorectal cancer. Hepatology. 59:202–215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kasinski AL, Kelnar K, Stahlhut C,
Orellana E, Zhao J, Shimer E, Dysart S, Chen X, Bader AG and Slack
FJ: A combinatorial microRNA therapeutics approach to suppressing
non-small cell lung cancer. Oncogene. 27:3547–3555. 2014.
|
|
18
|
Okamoto K, Miyoshi K and Murawaki Y:
miR-29b, miR-205 and miR-221 enhance chemosensitivity to
gemcitabine in HuH28 human cholangiocarcinoma cells. PLoS One.
8:e776232013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Muqbil I, Bao B, Abou-Samra AB, Mohammad
RM and Azmi AS: Nuclear export mediated regulation of microRNAs:
Potential target for drug intervention. Curr Drug Targets.
14:1094–1100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu JY, Yi W, Zhang MY, Xu R, Zeng LS, Long
XR, Zhou XM, Zheng XS, Kang Y and Wang HY: MicroRNA-711 is a
prognostic factor for poor overall survival and has an oncogenic
role in breast cancer. Oncol Lett. 11:2155–2163. 2016.PubMed/NCBI
|
|
21
|
Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu
L, Aisimitula A, Nie Y and Huang Q: Addition of rituximab to a CEOP
regimen improved the outcome in the treatment of non-germinal
center immunophenotype diffuse large B cell lymphoma cells with
high Bcl-2 expression. Int J Hematol. 99:79–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simsek EN and Uysal T: In vitro
investigation of cytotoxic and apoptotic effects of Cynara
L. species in colorectal cancer cells. Asian Pac J Cancer Prev.
14:6791–6795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mileo AM and Miccadei S: Polyphenols as
Modulator of Oxidative Stress in Cancer Disease: New Therapeutic
Strategies. Oxid Med Cell Longev. 2016:2016.6475624 View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu CJ, Zhou L and Cai Y:
Dihydroartemisinin induces apoptosis of cervical cancer cells via
upregulation of RKIP and downregulation of bcl-2. Cancer Biol Ther.
15:279–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
